Global celebrities ignite a weight‑loss craze as Elon Musk endorses Semaglutide!

Not only former UK Prime Minister Boris Johnson and Tesla founder Elon Musk, but a growing number of middle‑ and upper‑class individuals around the world—alongside political figures, business leaders, entertainers, and social‑media opinion leaders (KOLs)—are turning to semaglutide for weight and health management.

Since its launch, semaglutide has rapidly become a public sensation. On platforms like TikTok, the hashtag “#semaglutide” has amassed hundreds of millions of views and has been hailed as the next‑generation “fat‑melting miracle.” A host of celebrities and influencers have personally vouched for its effects, driving its popularity ever higher.

Semaglutide was first approved in 2017. In 2021, the U.S. Food and Drug Administration (FDA) granted it an additional indication for treating obesity in adults, and in January 2023 expanded that approval to include adolescents—making it one of the very few therapies worldwide formally recognized by the FDA for weight loss.

Its mechanism of action centers on activating the GLP‑1 receptor in a glucose‑dependent manner to boost insulin secretion and suppress glucagon release, while delaying gastric emptying, enhancing satiety, and inhibiting the hypothalamic centers that drive appetite. These combined effects deliver both improved glycemic control and significant weight reduction.

Former Prime Minister Boris Johnson: “Semaglutide changed my eating habits.”

In his first column, Johnson took the lead in sharing his personal experience with Semaglutide. During his tenure, he observed a noticeable change in the body shapes of his colleagues and became interested. On the advice of his doctor, he started using the drug, and within a few weeks he noticed a noticeable decrease in appetite, less frequent eating, and he could even easily give up desserts and extra meals.

He admitted that this drug simulates the human body's hormone signals to transmit fullness messages to the hypothalamus of the brain, thereby suppressing appetite. For many years, scientists have been working to mimic this type of hormone and finally successfully developed Semaglutide.

Elon Musk: Semaglutide helps lose more than 30 pounds

In October 2022, Musk publicly stated on Twitter that he managed his weight through fasting and Wegovy (the trade name of Semaglutide). He revealed that he successfully lost about 30 pounds (about 13.6 kilograms) through this. This statement received a lot of attention, further boosting the drug's popularity and usage in the mainstream community.

Well-known host: Half of the people I know are using Semaglutide

Jeremy Clarkson, former host of Top Gear in the UK, admitted in his column in the Sunday Times that half of the people around him are using Semaglutide maintains good figure.

He started taking it after being evaluated by a doctor and said: "Even if there was half a roast chicken and a bottle of wine in the refrigerator, I had no appetite at all." He was impressed by the appetite-suppressing effect.

Social KOL: From Curve Adjustment to Healthy Return

Not only traditional celebrities, but also social media influencers with a large number of fans have become loyal users of semaglutide:

• Shannon Natalia had long suffered from lipedema, a chronic condition that causes abnormal accumulation of fat in the extremities. She successfully lost about 20 kilograms by using semaglutide, and her transformation process attracted widespread attention.
• Under the guidance of a doctor, Madison Peoples combined exercise and diet control and lost about 18 kilograms in eight months.
• Mez Maraki once weighed 139 kilograms. After five months of medication, he lost about 18 kilograms and is still continuing to improve his body shape.

Starting out as a diabetes treatment agent, semaglutide has further expanded to the treatment of obesity. In 2021, it received FDA approval for chronic weight control, becoming a landmark breakthrough in the field of weight loss.